日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

路易体病中血浆多巴脱羧酶水平升高是由多巴胺能治疗引起的。

Bolsewig, Katharina; Willemse, Eline A J; Sánchez-Juan, Pascual; Rábano, Alberto; Martínez, Minerva; Doecke, James D; Bellomo, Giovanni; Vermunt, Lisa; Alcolea, Daniel; Halbgebauer, Steffen; In 't Veld, Sjors; Mattsson-Carlgren, Niklas; Veverova, Katerina; Fowler, Christopher J; Boonkamp, Lynn; Koel-Simmelink, Marleen; Hussainali, Zulaiga; Ruiters, Daimy N; Gaetani, Lorenzo; Toja, Andrea; Fortea, Juan; Pijnenburg, Yolande; Lemstra, Afina W; van der Flier, Wiesje M; Hort, Jakub; Otto, Markus; Hansson, Oskar; Parnetti, Lucilla; Masters, Colin L; Lleó, Alberto; Teunissen, Charlotte E; Del Campo Milán, Marta

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

对血浆 P-tau 亚型 P-tau181、P-tau217 和 P-tau231 的六种 Simoa 检测进行临床和分析比较

Sherif Bayoumy #, Inge M W Verberk #, Ben den Dulk, Zulaiga Hussainali, Marissa Zwan, Wiesje M van der Flier, Nicholas J Ashton, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant, Erik Stoops, Eugeen Vanmechelen, Jeffrey L Dage, Charlotte E Teunissen